CLINICAL TRIALS PROFILE FOR DIFLUPREDNATE
✉ Email this page to a colleague
All Clinical Trials for difluprednate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00405496 ↗ | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis | Completed | Sirion Therapeutics, Inc. | Phase 2 | 2000-03-01 | The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis. |
NCT00406341 ↗ | Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation | Completed | Sirion Therapeutics, Inc. | Phase 3 | 2004-04-01 | The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation. |
NCT00406497 ↗ | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation | Completed | Sirion Therapeutics, Inc. | Phase 2 | 2003-04-01 | The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation. |
NCT00406887 ↗ | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis | Completed | Sirion Therapeutics, Inc. | Phase 3 | 2002-08-01 | The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis. |
NCT00407056 ↗ | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis | Completed | Sirion Therapeutics, Inc. | Phase 3 | 2002-08-01 | The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis. |
NCT00407225 ↗ | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation | Completed | Sirion Therapeutics, Inc. | Phase 2 | 1999-12-01 | The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation. |
NCT00429923 ↗ | Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a) | Completed | Sirion Therapeutics, Inc. | Phase 3 | 1969-12-31 | The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for difluprednate
Condition Name
Clinical Trial Locations for difluprednate
Trials by Country
Clinical Trial Progress for difluprednate
Clinical Trial Phase
Clinical Trial Sponsors for difluprednate
Sponsor Name